-
16 October 2019
Selvita and Ryvu Therapeutics Announce Independent Trading
on the Warsaw Stock Exchange
-
01 October 2019
Ryvu Therapeutics and Selvita Announce registration of Corporate Split by the National Court Register of Poland
-
19 September 2019
Selvita announces shareholder approval of corporate split and new name of Ryvu Therapeutics for oncology development company
-
09 September 2019
Polish Financial Supervision Authority approves Selvita Cro prospectus, allowing corporate split into two separately listed companies to proceed
-
28 March 2019
Selvita to separate oncology therapeutics and contract research business units into two global companies
